




Searching News Database: herpes labialis
HSMN NewsFeed - 1 Jul 2019
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
HSMN NewsFeed - 18 Feb 2010
Medivir partners with Meda to commercialize Xerese(TM) (Lipsovir(R)) in North America
Medivir partners with Meda to commercialize Xerese(TM) (Lipsovir(R)) in North America
HSMN NewsFeed - 16 Dec 2009
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
HSMN NewsFeed - 13 Feb 2009
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
HSMN NewsFeed - 9 Feb 2009
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
HSMN NewsFeed - 5 Jul 2007
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
HSMN NewsFeed - 1 May 2007
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
HSMN NewsFeed - 8 Mar 2007
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
HSMN NewsFeed - 1 Feb 2007
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
HSMN NewsFeed - 3 Oct 2006
Transport Pharmaceuticals Hires Vice President of Quality Systems and Operational Excellence
Transport Pharmaceuticals Hires Vice President of Quality Systems and Operational Excellence
HSMN NewsFeed - 28 Sep 2006
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
HSMN NewsFeed - 27 Sep 2006
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Additional items found! 15

Members Archive contains
15 additional stories matching:
herpes labialis
(Password required)
herpes labialis
(Password required)